Based on the findings, it can be concluded that the impacts of lncRNAs is mainly through disruption of miRNAs regulatory pathways and increasing the expression of ABC transporters, which finally lead to pumping tumor suppression drugs out of the CML cells. The gene discussed is ABCG2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.